Pulse Check: The Cardiovascular Conversations

Mark Lovern, Ph. D.

Dr Mark Lovern is Executive Director of Medical Science Services at Fortrea, and has 25+ years of experience in the application of model-informed drug development (MIDD).

Dr Jim Bush

Dr. Jim Bush, Vice President Medical Services, Clinical Pharmacology and Principal Investigator. Dr.

A patient-centric approach to advance respiratory drug development

Targeting the heart of the problem: why coronary inflammation is cardiovascular medicine's next frontier

Three key insights from NeuPSIG 2025 that are reshaping chronic pain research

Smarter, faster, better: How AI is reshaping neuroscience clinical trials

How can neuroscience clinical trial sponsors use AI to reduce complexity, accelerate timelines and lower costs in a high-risk, delay-prone research environment?

Cortex Conversations: Insights in Neuroscience

Choosing the right AI vendor for clinical trials in a rapidly evolving landscape

Choosing the right AI vendor can transform your clinical trial strategy. Explore key questions to shape effective, future-ready collaborations.